सत्याधीशसत्याधीश
SatyaDheesh
India's Ground Truth Record
Pull to refresh
VOL. I · EST. 11.2025 
SatyaDheesh
सत्याधीश
India's Ground Truth Record
LIVE

Science Corporation implants PRIMA chip to help Stargardt disease patient see letters

GS3Economy · S&T · Environment · Security· Biotechnology & health research· Prelims + Mains·

BCI technology and neurotechnology applications in healthcare: a key GS3 Science & Technology topic.

Why in news

Science Corporation CEO Max Hodak announced the successful implantation of the PRIMA chip in a Stargardt disease patient to enable the perception of black and white letters.

Background

The PRIMA chip is a 2mm by 2mm brain-computer interface (BCI) implant. It was first implanted in May at Sydney Eye Hospital to assist a patient with Stargardt disease.

Facts for Prelims

  • S&TPRIMA chip: A brain-computer interface (BCI) technology developed by Science Corporation.
  • FactPRIMA chip dimensions: 2mm by 2mm.
  • PostMax Hodak: CEO of Science Corporation and former co-founder of Neuralink.
  • PlaceSydney Eye Hospital: Location of the first PRIMA chip implantation.

Prelims practice question

With reference to the PRIMA chip technology, consider the following statements:

  1. The chip has dimensions of 5mm by 5mm.
  2. The first implantation took place at Sydney Eye Hospital.
  3. The PRIMA chip is a brain-computer interface (BCI) technology.

Which of the statements given above is/are correct?

  1. (a)1 only
  2. (b)1 and 3 only
  3. (c)2 and 3 only
  4. (d)1, 2 and 3
Show answer

Answer: (c) 2 and 3 only — Statements 2 and 3 are correct. Statement 1 is incorrect: The chip dimensions are 2mm by 2mm.

For Mains

Q. Discuss the ethical implications and regulatory challenges associated with the advancement of brain-computer interface (BCI) technologies in treating neurodegenerative diseases.

Dimensions to cover in your answer

  • Data privacy: Risks of unauthorized access to neural data or cognitive patterns
  • Equity of access: High costs of BCI implants potentially widening the health-inequality gap
  • Regulatory vacuum: Lack of specific legal frameworks for 'engineered brains' and neural enhancements

Keywords: Brain-Computer Interface · Neurotechnology · Neural Ethics · Biotechnology · Neurodegenerative Diseases

Read the full news →Report a mistake in this noteHow notes are madeSource: TechCrunch ↗Also: GS4 · Ethics in technology & business

More Science & Technology notes

All Science & Technology current affairs →

Something wrong, or something missing?

Spotted a mistake in a note, or want a topic, format or PDF that would help your preparation? Write to us. We read every mail and fix errors fast.

Report a mistake →Ask for something →[email protected]

This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.